Stocks Hitting 52-Week Highs

Arena Pharmaceuticals

shares jumped 8.10% to create a new 52-week high of $9.08. The Food and Drug Administration is scheduled to make a decision on the company's experimental obesity drug lorcaserin by June 27. Henry Schein

shares gained 1.14% to touch a new 52-week high of $78.71. Henry Schein's PEG ratio is 1.51. Cerner

shares rose 3.59% to create a new 52-week high of $85.61. Cerner and Corniche Hospital introduced the positive patient identification program to improve patient health outcomes and safety. Smart Balance

shares gained 3.25% to create a new 52-week high of $8.26. Smart Balance shares have jumped 50.38% over the past 52 weeks, while the S&P 500 index has gained 5.61% in the same period.